Cytosorbents (CTSO) vs Tenon Medical (TNON)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cytosorbents (CTSO) has outperformed Tenon Medical (TNON) over the past year, losing 80.9% versus a loss of 91.8%. Cytosorbents is the larger company by market cap ($11.8 million vs $9.2 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTSO | TNON |
|---|---|---|
| Share price | $3.73 | $3.44 |
| Market cap | $11.75M | $9.25M |
| 1-day change | -3.62% | -1.71% |
| YTD return | -70.81% | -89.68% |
| 1-year return | -80.87% | -91.81% |
| 5-year return | -96.82% | — |
| EPS (TTM) | $-5.80 | $-44.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.72 | $50.40 |
| 52-week low | $3.66 | $2.40 |
| Distance from 52-week high | -81.09% | -93.17% |
| Analyst consensus | none | none |
| Avg. price target upside | +1173.46% | +1190.12% |
| Average volume | 12.45K | 6.40M |
| Shares outstanding | 3.15M | 2.69M |
| Employees | 129 | 26 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CTSO has outperformed TNON by 10.9 percentage points over the past year.
About Cytosorbents
CTSO stock →Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform in the United States, Germany, and internationally. Its flagship product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses, bilirubin in liver failure, myoglobin in trauma and critical illnesses, and inflammatory mediators and blood thinners in cardiac surgery applications, as well as to remove antithrombotic drugs and inflammatory mediators in cardiothoracic surgery applications.
Healthcare · Medical Devices · 129 employees
About Tenon Medical
TNON stock →Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.
Healthcare · Medical Devices · 26 employees
CTSO vs TNON FAQ
Which is bigger, Cytosorbents or Tenon Medical?
Cytosorbents (CTSO) is larger, with a market capitalization of $11.75M compared with $9.25M for Tenon Medical (TNON).
Which stock has performed better over the past year, CTSO or TNON?
CTSO returned -80.87% over the past 12 months, compared with -91.81% for TNON (price return, excluding dividends). Past performance does not predict future results.
Are Cytosorbents and Tenon Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.